DrugPatentWatch Database Preview

Hikma Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and sixty approved drugs.

There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.

Summary for Hikma

US Patents:	5
Tradenames:	121
Ingredients:	114
NDAs:	160
Patent Litigation for Hikma:	See patent lawsuits for Hikma
PTAB Cases with Hikma as petitioner:	See PTAB cases with Hikma as petitioner

Drugs and US Patents for Hikma

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Intl Pharms	ISOSORBIDE DINITRATE	isosorbide dinitrate	TABLET;ORAL	086067-001	Oct 29, 1987	AB	RX	No	No
Hikma Farmaceutica	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	204360-001	Oct 15, 2018	AP	RX	No	No
Hikma Intl Pharms	AMINOPHYLLINE	aminophylline	TABLET;ORAL	084540-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Hikma Farmaceutica	BUTORPHANOL TARTRATE	butorphanol tartrate	INJECTABLE;INJECTION	078400-001	May 1, 2009	AP	RX	No	No
Hikma Pharms	TOPIRAMATE	topiramate	TABLET;ORAL	091185-003	Nov 25, 2013		DISCN	No	No

Paragraph IV (Patent) Challenges for HIKMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	0.6 mg		2016-06-10
	Injection	1 mg/mL, 50 mL vials		2011-12-16
	Injection	100 mg/mL, 2.5 mL vials		2007-09-24

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Hikma
• Hikma Farmaceutica
• Hikma Intl Pharms
• Hikma Pharm Co Ltd
• Hikma Pharms